2021-2022 Special Opportunity: RTFCCR-MRA Team Science Awards on Patient- Centric Melanoma Clinical Trials

The Melanoma Research Alliance (MRA) is pleased to announce a Special Opportunity Request for Proposals (RFP) for Team Science Awards focused on patient-centric clinical trials, jointly funded by The Rising Tide Foundation for Clinical Cancer Research (RTFCCR) and MRA. MRA and RTFCCR intend to support two awards through this partnership.

Teams must be multidisciplinary, with at least two established Principal Investigators, and one a Young Investigator with complementary expertise, and a Mentor for the Young Investigator.

Funding: $1,500,000 per year

Duration: 5 years 

Research Authority due date: 22.9.22

LOI (required) due date: 5.10.22

Full proposal due date: 18.1.23